10.58 USD
↗ 0.38 (3.73%)LIVE (AS OF 03:21 PM EDT)
Fennec Pharmaceuticals Inc. Common Stock
FENCNASDAQ • USD
Market: OPEN
Fennec Pharmaceuticals Inc. Common Stock (FENC) is currently trading at $10.58. There is a divergence between signals — underlying fundamentals rate "Buy" but technical indicators lean "Strong Sell". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place FENC at a fair price relative to peers.
Technical & fundamental data as of Oct 2, 2026.
Open?$10.18
High?$10.63
Low?$9.98
Prev. Close?$10.20
Volume?65.4K
Avg. Volume?215.5K
VWAP?$10.32
Rel. Volume?0.30x
Bid / Ask
Bid?$8.96 × 100
Ask?$12.08 × 100
Spread?$3.12
Midpoint?$10.52
Valuation & Ratios
Market Cap?357.7M
Shares Out?35.1M
Float?22.1M
Float %?63.1%
P/E Ratio?N/A
P/B Ratio?8.43
EPS?-$0.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Employees
35
Market Cap
357.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2002-01-28
Address
PO BOX 13628
RESEARCH TRIANGLE PARK, NC 27709
Phone: (919) 636-4530
RESEARCH TRIANGLE PARK, NC 27709
Phone: (919) 636-4530
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?91
Momentum?90
Short Sent.?64
Piotroski F-Score?6/9Mixed
Altman Z-Score?3.93Safe
Confidence?71%Moderate
Short InterestLow
Short % of Float?2.46%Low
Short Interest?545.0K
Days to Cover?2.1
Free Float22.1M
Avg Daily Volume258.4K
Settlement Date2026-09-15
Financial Health
Current Ratio?5.85Strong
Quick Ratio?5.66Strong
Cash Ratio?3.33Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?8.43HIGH▾
Peers100
S&P22
P/S?6.04FAIR▾
Peers100
S&P22
P/FCF?N/A▾
EV/EBITDA?-281.3CHEAP▾
S&P97
EV/Sales?5.34FAIR▾
Peers100
S&P33
Returns & Efficiency
ROE?-7.7%WEAK▾
S&P10
ROA?-4.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-2040000
Enterprise Value?$316.4M
Fundamentals ratios updated end of day